[Treatment of dyspeptic disorders, lithiasis and biliary dyskinesia with ursodeoxycholic acid. Analysis of a controlled multicenter study].
The effect of ursodesoxycholic acid (UDCA) on dyspeptic symptoms and pain in cholelithiasis and biliary dyskinesia has been investigated in a double blind trial. The results obtained in 661 patients investigated after 7 and 14 days of treatment show a significantly superior effect of UDCA compared with placebo.
D001657:Biliary Dyskinesia / Q000188:drug therapy*; D002769:Cholelithiasis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D004311:Double-Blind Method; D004415:Dyspepsia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010919:Placebos; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D010919:Placebos; D003840:Deoxycholic Acid; D014580:Ursodeoxycholic Acid
Le traitement des troubles dyspeptiques, de la lithiase et de la dyseinésie biliaires avec l'acide ursodésoxycholique. Analyse d'une recherche multicentrique contr$olée.